Intended for healthcare professionals

Rapid response to:

Editor's Choice

Covid 19: Where’s the strategy for testing?

BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2518 (Published 26 June 2020) Cite this as: BMJ 2020;369:m2518

Read our latest coverage of the coronavirus pandemic

Rapid Response:

Re: Covid 19: Where’s the strategy for testing?

Dear Editor

We are currently testing under capacity in England and Wales. Testing is limited to subjects showing a high temperature, a new and/or persistent cough and/or loss of taste and smell. The CDC [1] lists 11 symptoms including fatigue, muscle aches, headache and diarrhoea. We also know that Covid 19 can produce a variety of cardiovascular symptoms including thrombosis, stroke, myocardial infarction and vasculitis.

This means we are missing staff and patients with these symptoms who may have serious illness and be infecting others. It is time we were much more proactive about widening our testing criteria.

https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html...

Competing interests: No competing interests

28 June 2020
Michael R Rees
Professor of Cardiovascular Studies
Bangor University
Brigantia Building, Penrallt road